Check Palexia strips: TGA

A labelling problem has seen Seqirus undertake a product defect correction over one batch of Palexia The TGA has advised consumers and health professionals that in consultation with the TGA, the company has undertaken a product defect correction involving a batch of Palexia 100mg sustained-release (SR) tapentadol tablets due to a labelling fault. “Some packages

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Poll: Are patients giving you a hard time?
Next Dispute over pharmacy approval